— Know what they know.
Not Investment Advice

VTVT NASDAQ

vTv Therapeutics Inc.
1W: +1.2% 1M: -8.5% 3M: -11.5% YTD: -22.8% 1Y: +27.4% 3Y: +68.7% 5Y: -56.8%
$30.57
-1.28 (-4.02%)
 
Weekly Expected Move ±4.9%
$28 $29 $31 $32 $34
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 42 · $80.0M mcap · 1M float · 4.55% daily turnover · Short 56% of daily vol

Balance Sheet Trends

Total Assets
$90M +134.9% ▲
5Y CAGR: +43.5%
Total Liabilities
$25M +6.2% ▲
5Y CAGR: +18.3%
Shareholders Equity
$64M +428.2% ▲
Cash & Investments
$89M +142.0% ▲
5Y CAGR: +73.0%
Total Debt
$0 -100.0% ▼
Net Debt
-$89M -143.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$13M$12M$9M$37M$89M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$13M$12M$9M$37M$89M
Net Receivables$57K$12M$102K$62K$0
Inventory$100K$0$0$0$0
Other Current Assets$35K$0$0$0$961K
Total Current Assets$16M$27M$11M$38M$90M
Property, Plant & Equip.$680K$556K$361K$153K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$9M$6M$0$0$0
Other Non-Current Assets$0$0$0$0$6K
Total Non-Current Assets$10M$6M$361K$153K$6K
Total Assets$25M$33M$11M$38M$90M
— Liabilities —
Accounts Payable$2M$2M$4M$939K$1M
Short-Term Debt$256K$224K$191K$0$0
Deferred Revenue$35K$17K$17K$0$0
Other Current Liabilities$3M$788K$5M$2M$6M
Total Current Liabilities$8M$8M$11M$5M$7M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$1M$684K$110K$100K$152K
Total Non-Current Liabilities$2M$20M$19M$19M$19M
Total Liabilities$10M$27M$30M$24M$25M
— Equity —
Common Stock$901K$27K$27K$32K$39K
Retained Earnings-$249M-$266M-$281M-$300M-$327M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$10M-$11M-$25M$12M$64M
Total Liabilities & Equity$25M$33M$11M$38M$90M
— Key Metrics —
Total Debt$932K$716K$529K$169K$0
Net Debt-$12M-$11M-$9M-$37M-$89M
Total Investments$9M$6M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms